1)  γ-ray
肝癌 H22
2)  H22 liver cancer
H22肝癌
1.
Objective: To observe whether insulin can enhance the chemotherapeutic response of 5-fluorouracil(5-FU) in transplanted H22 liver cancer in nude mice and to investigate the underlying mechanism.
目的:建立裸鼠H22肝癌移植瘤模型,观察胰岛素是否增强5-氟脲嘧啶(5-FU)对裸鼠移植瘤的化疗疗效并探讨其机制。
2.
Methods:Transplanted tumor H22 liver cancer in mice were made,filling on 5‰CMC, high,moderate,low dosage .
目的:观察小柴胡汤及药群配伍对小鼠 H22肝癌实体瘤及免疫器官的影响,明确小柴胡汤抗肝肿瘤的作用及量效关系,探讨小柴胡汤及药群内在配伍意义。
3)  H22 hepatoma
H22肝癌
1.
RESULTS At the dose of 1,6 and 12 mg/kg,Polysaccharide from fermented Tremella fuciformis exhibit certain inhibition effect on U14 cervical cancer, H22 hepatoma and S180 sarcoma in mice.
目的:研究银耳孢子多糖对小鼠U14宫颈癌、H22肝癌、S180肉瘤的抑制作用。
2.
Objective:To study the synergistic effects of ethanol extracts from honeybee hives on the therapeutic efficacy of chemotherapy and radiotherapy to transplanted H22 hepatoma in mice.
目的:观察蜂房乙醇提取物对荷H22肝癌小鼠的放化疗增效作用。
3.
Objective:To detect the expression of CD69 molecular on activated spleen lymphocyte of H22 hepatoma bear- ing mice in vitro.
目的:检测H22肝癌荷瘤鼠体外活化脾淋巴细胞CD69分子的表达。
4)  H22 hepatocarcinoma
H22肝癌
1.
Objective:To investigate the dose-chemotactic effect relationship of secondary lymphoid tissue chemokine(SLC) eukaryotic expression plasmid and the dose-effect relationship of SLC plasmid on mouse H22 hepatocarcinoma.
目的:观察次级淋巴组织趋化因子(SLC)真核表达质粒剂量-趋化效应关系及不同剂量体内应用时对小鼠H22肝癌的治疗作用。
5)  H22 Hepatocellular Carcinoma Cells
肝癌H22
1.
Effects of E838 in Combination with γ-ray on H22 Hepatocellular Carcinoma Cells of Mice;
E838联合γ射线对小鼠肝癌H22抑瘤作用的实验研究
6)  H22 hepatoma mice
肝癌H22小鼠
参考词条
补充资料:(22E,24R)-麦角甾烷-5,7,22-三烯-3β醇
分子式:C28H44O
分子量:396.66
CAS号:57-87-4

性质:片状结晶(乙醇)或针状结晶(乙醚)。含1.5mol结晶水者,熔点168℃。沸点250℃/1.4Pa。[α]20/D-135°(C1.2,氯仿)。

制备方法:由从葡萄糖合成该品的酵母中提取。

用途:是生产维生素D2的前体,也是生产激素类药物的中间体,可用来生产可的松。

说明:补充资料仅用于学习参考,请勿用于其它任何用途。